Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

3.60
Delayed Data
As of 9:45am ET
 -0.17 / -4.51%
Today’s Change
0.65
Today|||52-Week Range
5.76
+62.16%
Year-to-Date
No recent news for ContraVir Pharmaceuticals Inc.

Today’s Trading

Previous close3.77
Today’s open3.74
Day’s range3.60 - 3.74
Volume736
Average volume (3 months)90,525
Market cap$84.0M
Dividend yield--
Data as of 9:45am ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-1,950.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OGENOragenics Inc+0.47+20.61%
APRIApricus Biosciences ...-0.07-4.14%
BLRXBioLine RX Ltd+0.09+5.69%
VTLVital Therapies Inc-0.06-1.66%
Data as of 11:19am ET, 09/03/2015

Financials

Last reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$5.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
James E. Sapirstein
Chief Financial Officer
William Hornung
Corporate headquarters
Edison, New Jersey

Forecasts

Partner Offers